Literature DB >> 25196378

A trifluorinated thiazoline scaffold leading to pro-apoptotic agents targeting prohibitins.

Alba Pérez-Perarnau1, Sara Preciado, Claudia Mariela Palmeri, Cristina Moncunill-Massaguer, Daniel Iglesias-Serret, Diana M González-Gironès, Miriam Miguel, Satoki Karasawa, Satoshi Sakamoto, Ana M Cosialls, Camila Rubio-Patiño, José Saura-Esteller, Rosario Ramón, Laia Caja, Isabel Fabregat, Gabriel Pons, Hiroshi Handa, Fernando Albericio, Joan Gil, Rodolfo Lavilla.   

Abstract

A new class of small molecules, with an unprecedented trifluorothiazoline scaffold, were synthesized and their pro-apoptotic activity was evaluated. With an EC50 in the low micromolar range, these compounds proved to be potent inducers of apoptosis in a broad spectrum of tumor cell lines, regardless of the functional status of p53. Fast structure-activity relationship studies allowed the preparation of the strongest apoptosis-inducing candidate. Using a high performance affinity purification approach, we identified prohibitins 1 and 2, key proteins involved in the maintenance of cell viability, as the targets for these compounds.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antitumor agents; drug discovery; fluorine; heterocycles; medicinal chemistry

Mesh:

Substances:

Year:  2014        PMID: 25196378     DOI: 10.1002/anie.201405758

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  12 in total

1.  The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells ex vivo but fails to prevent leukemia development in a murine model.

Authors:  Marina Wierz; Sandrine Pierson; Nora Chouha; Laurent Désaubry; Jean-Hugues François; Guy Berchem; Jerome Paggetti; Etienne Moussay
Journal:  Haematologica       Date:  2018-01-05       Impact factor: 9.941

Review 2.  Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Authors:  Dong Wang; Redouane Tabti; Sabria Elderwish; Hussein Abou-Hamdan; Amel Djehal; Peng Yu; Hajime Yurugi; Krishnaraj Rajalingam; Canan G Nebigil; Laurent Désaubry
Journal:  Cell Mol Life Sci       Date:  2020-02-15       Impact factor: 9.261

3.  The prohibitin-binding compound fluorizoline affects multiple components of the translational machinery and inhibits protein synthesis.

Authors:  Xin Jin; Jianling Xie; Michael Zabolocki; Xuemin Wang; Tao Jiang; Dong Wang; Laurent Désaubry; Cedric Bardy; Christopher G Proud
Journal:  J Biol Chem       Date:  2020-05-19       Impact factor: 5.157

4.  Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours.

Authors:  H Yurugi; F Marini; C Weber; K David; Q Zhao; H Binder; L Désaubry; K Rajalingam
Journal:  Oncogene       Date:  2017-04-17       Impact factor: 9.867

Review 5.  Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.

Authors:  Jie Yang; Bin Li; Qing-Yu He
Journal:  Cell Death Dis       Date:  2018-05-21       Impact factor: 8.469

6.  The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells through the upregulation of NOXA and synergizes with ibrutinib, 5-aminoimidazole-4-carboxamide riboside or venetoclax.

Authors:  Ana M Cosialls; Helena Pomares; Daniel Iglesias-Serret; José Saura-Esteller; Sonia Núñez-Vázquez; Diana M González-Gironès; Esmeralda de la Banda; Sara Preciado; Fernando Albericio; Rodolfo Lavilla; Gabriel Pons; Eva M González-Barca; Joan Gil
Journal:  Haematologica       Date:  2017-06-15       Impact factor: 9.941

7.  New Thiazoline-Tetralin Derivatives and Biological Activity Evaluation.

Authors:  Gülhan Turan-Zitouni; Leyla Yurttaş; Aouatef Tabbi; Gülşen Akalın Çiftçi; Halide Edip Temel; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2018-01-10       Impact factor: 4.411

Review 8.  Mitochondrial Quality Control Mechanisms and the PHB (Prohibitin) Complex.

Authors:  Blanca Hernando-Rodríguez; Marta Artal-Sanz
Journal:  Cells       Date:  2018-11-29       Impact factor: 6.600

9.  A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation.

Authors:  Cristina Moncunill-Massaguer; José Saura-Esteller; Alba Pérez-Perarnau; Claudia Mariela Palmeri; Sonia Núñez-Vázquez; Ana M Cosialls; Diana M González-Gironès; Helena Pomares; Anne Korwitz; Sara Preciado; Fernando Albericio; Rodolfo Lavilla; Gabriel Pons; Thomas Langer; Daniel Iglesias-Serret; Joan Gil
Journal:  Oncotarget       Date:  2015-12-08

10.  Targeting prohibitins induces apoptosis in acute myeloid leukemia cells.

Authors:  Helena Pomares; Claudia M Palmeri; Daniel Iglesias-Serret; Cristina Moncunill-Massaguer; José Saura-Esteller; Sonia Núñez-Vázquez; Enric Gamundi; Montserrat Arnan; Sara Preciado; Fernando Albericio; Rodolfo Lavilla; Gabriel Pons; Eva M González-Barca; Ana M Cosialls; Joan Gil
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.